» Articles » PMID: 19144939

Cumulative Live-birth Rates After in Vitro Fertilization

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2009 Jan 16
PMID 19144939
Citations 138
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Outcomes of in vitro fertilization (IVF) treatment are traditionally reported as pregnancies per IVF cycle. However, a couple's primary concern is the chance of a live birth over an entire treatment course.

Methods: We estimated cumulative live-birth rates among patients undergoing their first fresh-embryo, nondonor IVF cycle between 2000 and 2005 at one large center. Couples were followed until either discontinuation of treatment or delivery of a live-born infant. Analyses were stratified according to maternal age and performed with the use of both optimistic and conservative methods. Optimistic methods assumed that patients who did not return for subsequent IVF cycles would have the same chance of a pregnancy resulting in a live birth as patients who continued treatment; conservative methods assumed no live births among patients who did not return.

Results: Among 6164 patients undergoing 14,248 cycles, the cumulative live-birth rate after 6 cycles was 72% (95% confidence interval [CI], 70 to 74) with the optimistic analysis and 51% (95% CI, 49 to 52) with the conservative analysis. Among patients who were younger than 35 years of age, the corresponding rates after six cycles were 86% (95% CI, 83 to 88) and 65% (95% CI, 64 to 67). Among patients who were 40 years of age or older, the corresponding rates were 42% (95% CI, 37 to 47) and 23% (95% CI, 21 to 25). The cumulative live-birth rate decreased with increasing age, and the age-stratified curves (< 35 vs. > or = 40 years) were significantly different from one another (P<0.001).

Conclusions: Our results indicate that IVF may largely overcome infertility in younger women, but it does not reverse the age-dependent decline in fertility.

Citing Articles

Biosimilars versus the originator of follitropin alfa for ovarian stimulation in ART: a systematic review and meta-analysis.

Kiose K, Storr A, Kolibianakis E, Mol B, Venetis C Hum Reprod. 2024; 40(2):343-359.

PMID: 39719046 PMC: 11788201. DOI: 10.1093/humrep/deae274.


The costs per live birth after uterus transplantation: results of the Swedish live donor trial.

Brannstrom M, Ekberg J, Sandman L, Davidson T Hum Reprod. 2024; 40(2):310-318.

PMID: 39675045 PMC: 11788207. DOI: 10.1093/humrep/deae272.


Two-year cumulative live-birth rates and maximum number of transfer cycles in women aged ≥ 40 years.

Nukaga S, Tokoro M, Asano E, Inoue D, Hashiba Y, Fukunaga N Sci Rep. 2024; 14(1):24814.

PMID: 39438490 PMC: 11496526. DOI: 10.1038/s41598-024-74460-y.


Sperm histone modifications may predict success in human assisted reproduction: a pilot study.

Cambiasso M, Romanato M, Gotfryd L, Valzacchi G, Calvo L, Calvo J J Assist Reprod Genet. 2024; 41(11):3147-3159.

PMID: 39419944 PMC: 11621280. DOI: 10.1007/s10815-024-03280-w.


Patients with low prognosis in ART: a Delphi consensus to identify potential clinical implications and measure the impact of POSEIDON criteria.

Alviggi C, Humaidan P, Fischer R, Conforti A, Dahan M, La Marca A Reprod Biol Endocrinol. 2024; 22(1):122.

PMID: 39385174 PMC: 11465546. DOI: 10.1186/s12958-024-01291-x.